Structure/function of the soluble guanylyl cyclase catalytic domain

被引:26
|
作者
Childers, Kenneth C. [1 ]
Garcin, Elsa D. [1 ]
机构
[1] Univ Maryland Baltimore Cty, Dept Chem & Biochem, 1000 Hilltop Circle, Baltimore, MD 21250 USA
来源
基金
美国国家卫生研究院;
关键词
Soluble guanylyl cyclase; Adenylyl cyclase; Catalytic domain; Nitric oxide; S-nitrosation; Activation mechanism; NITRIC-OXIDE RECEPTOR; ADENYLYL-CYCLASE; CRYSTAL-STRUCTURE; YC-1; BINDING; FUNCTIONAL-CHARACTERIZATION; DIFFERENTIAL INHIBITION; SIGNALING HELIX; BETA-1; SUBUNIT; HEME; ACTIVATION;
D O I
10.1016/j.niox.2018.04.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Soluble guanylyl cyclase (GC-1) is the primary receptor of nitric oxide (NO) in smooth muscle cells and maintains vascular function by inducing vasorelaxation in nearby blood vessels. GC-1 converts guanosine 5'-triphosphate (GTP) into cyclic guanosine 3',5'-monophosphate (cGMP), which acts as a second messenger to improve blood flow. While much work has been done to characterize this pathway, we lack a mechanistic understanding of how NO binding to the heme domain leads to a large increase in activity at the C-terminal catalytic domain. Recent structural evidence and activity measurements from multiple groups have revealed a low-activity cyclase domain that requires additional GC-1 domains to promote a catalytically-competent conformation. How the catalytic domain structurally transitions into the active conformation requires further characterization. This review focuses on structure/function studies of the GC-1 catalytic domain and recent advances various groups have made in understanding how catalytic activity is regulated including small molecules interactions, Cys-S-NO modifications and potential interactions with the NO-sensor domain and other proteins.
引用
收藏
页码:53 / 64
页数:12
相关论文
共 50 条
  • [41] Soluble guanylyl cyclase: more secrets revealed
    Pyriochou, A
    Papapetropoulos, A
    CELLULAR SIGNALLING, 2005, 17 (04) : 407 - 413
  • [43] Regulation of soluble guanylyl cyclase by protoporphyrin agonists
    Nedvetsky, PI
    Nedvetskaya, TY
    Schmidt, P
    Taye, A
    Müller, H
    Stasch, JF
    Schmidt, HHHW
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R39 - R39
  • [44] Molecular aspects of soluble guanylyl cyclase regulation
    Andreopoulos, S
    Papapetropoulos, A
    GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 2000, 34 (03): : 147 - 157
  • [45] On the activation of soluble guanylyl cyclase by nitric oxide
    Bellamy, TC
    Wood, J
    Garthwaite, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (01) : 507 - 510
  • [46] Soluble Guanylyl Cyclase and Coronary Vascular Reactivity
    Gao, Yuangsheng
    JOURNAL OF VASCULAR RESEARCH, 2014, 51 : 10 - 10
  • [47] Structural Determinants for the Activation of Soluble Guanylyl Cyclase
    Childers, Kenneth
    Giannakoulias, Sam
    Garcin, Elsa
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2018, 74 : A67 - A67
  • [48] PAS-mediated dimerization of soluble guanylyl cyclase revealed by signal transduction histidine kinase domain crystal structure
    Ma, Xiaolei
    Sayed, Nazish
    Baskaran, Padmamalini
    Beuve, Annie
    van den Akker, Focco
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (02) : 1167 - 1178
  • [49] Distribution of soluble guanylyl cyclase in rat retina
    Ding, Jin-Dong
    Weinberg, Richard J.
    JOURNAL OF COMPARATIVE NEUROLOGY, 2007, 500 (04) : 734 - 745
  • [50] Inhibition of soluble guanylyl cyclase by copper ions
    Schrammel, A
    Klatt, P
    Koesling, D
    Schmidt, K
    Mayer, B
    BIOLOGY OF NITRIC OXIDE, PT 5, 1996, 10 : 117 - 117